Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $7.49 in the prior trading day, Teladoc Health Inc (NYSE: TDOC) closed at $7.34, down -2.00%. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 4.78 million shares were traded. TDOC stock price reached its highest trading level at $7.705 during the session, while it also had its lowest trading level at $7.32.
Ratios:
Our goal is to gain a better understanding of TDOC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.45. For the most recent quarter (mrq), Quick Ratio is recorded 2.49 and its Current Ratio is at 2.59. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on July 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $10.
On November 15, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $14.
Jefferies reiterated its Hold rating for the stock on September 17, 2024, while the target price for the stock was revised from $8 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 03 ’25 when Rodrigues Fernando M. sold 4,174 shares for $6.91 per share. The transaction valued at 28,842 led to the insider holds 0 shares of the business.
Rodrigues Fernando M. sold 2,358 shares of TDOC for $16,176 on Jun 02 ’25. The President of BetterHelp now owns 4,174 shares after completing the transaction at $6.86 per share. On Jun 02 ’25, another insider, Vandervoort Adam C, who serves as the CHIEF LEGAL OFFICER, SECRETARY of the company, sold 5,808 shares for $6.86 each. As a result, the insider received 39,843 and left with 69,773 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1296912000 and an Enterprise Value of 1652380416. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at 0.65 whereas that against EBITDA is 87.511.
Stock Price History:
The Beta on a monthly basis for TDOC is 1.84, which has changed by -0.005420029 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is -4.77%, while the 200-Day Moving Average is calculated to be -16.42%.
Shares Statistics:
The stock has traded on average 7.13M shares per day over the past 3-months and 6390030 shares per day over the last 10 days, according to various share statistics. A total of 176.61M shares are outstanding, with a floating share count of 174.74M. Insiders hold about 1.11% of the company’s shares, while institutions hold 73.83% stake in the company. Shares short for TDOC as of 1753920000 were 24009369 with a Short Ratio of 3.37, compared to 1751241600 on 24587090. Therefore, it implies a Short% of Shares Outstanding of 24009369 and a Short% of Float of 15.2.
Earnings Estimates
The stock of Teladoc Health Inc (TDOC) is currently drawing attention from 3.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.24 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.84 and -$1.35 for the fiscal current year, implying an average EPS of -$1.21. EPS for the following year is -$0.96, with 4.0 analysts recommending between -$0.93 and -$0.99.
Revenue Estimates
23 analysts predict $625.66M in revenue for the current quarter. It ranges from a high estimate of $629.95M to a low estimate of $619.6M. As of the current estimate, Teladoc Health Inc’s year-ago sales were $640.51MFor the next quarter, 23 analysts are estimating revenue of $634.31M. There is a high estimate of $642.65M for the next quarter, whereas the lowest estimate is $621.4M.
A total of 24 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.53B, while the lowest revenue estimate was $2.5B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 24 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.62B and the low estimate is $2.49B.
